Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, Hanmei Xu · 2024
Read Nucleic acid drugs: recent progress and future perspectives by Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, Hanmei Xu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11604671.txt.
Description
Drugs built from DNA or RNA letters can reach targets that pills and antibodies cannot touch. Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, and Hanmei Xu review that drug class in a 2024 paper. The drugs edit or silence genes with high precision.
Their weak points are plain: they break down fast, stir the immune system, and slip poorly into cells. Chemical tweaks and carrier shells answer much of that. Some of these drugs have already won approval for patient use. The review maps classes, delivery routes, and what may come next. Delivery, the team stresses, stays the gate to wider use.
Catalog record
| CREATOR | Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, Hanmei Xu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 125 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |